Zhejiang Conba Pharmaceutical (600572.SH) announced that the company's Board of Directors recently received a submission from the company's president, Mr. Luo Guoliang...
According to a report from the Zhuntong Finance APP, Zhejiang Conba Pharmaceutical (600572.SH) announced that the Board of Directors recently received a written resignation letter from Mr. Luo Guoliang, the company's president, who applied to resign from the position of president due to reaching retirement age. After review by the Board of Directors, Mr. Luo Guoliang's resignation was accepted.
To adapt to the company's further acceleration of integration, strengthening management, and future development needs, the company's 11th Board of Directors, at its fifth (temporary) meeting, decided to appoint Mr. Jiang Yi, the chairman of the Board of Directors, to concurrently serve as the company's president, with the term of office effective from the date of this Board of Directors resolution until the expiration of the 11th Board of Directors.
